Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
- PMID: 32317267
- PMCID: PMC7190077
- DOI: 10.1136/bmj.m1443
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
Abstract
Objective: To evaluate viral loads at different stages of disease progression in patients infected with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first four months of the epidemic in Zhejiang province, China.
Design: Retrospective cohort study.
Setting: A designated hospital for patients with covid-19 in Zhejiang province, China.
Participants: 96 consecutively admitted patients with laboratory confirmed SARS-CoV-2 infection: 22 with mild disease and 74 with severe disease. Data were collected from 19 January 2020 to 20 March 2020.
Main outcome measures: Ribonucleic acid (RNA) viral load measured in respiratory, stool, serum, and urine samples. Cycle threshold values, a measure of nucleic acid concentration, were plotted onto the standard curve constructed on the basis of the standard product. Epidemiological, clinical, and laboratory characteristics and treatment and outcomes data were obtained through data collection forms from electronic medical records, and the relation between clinical data and disease severity was analysed.
Results: 3497 respiratory, stool, serum, and urine samples were collected from patients after admission and evaluated for SARS-CoV-2 RNA viral load. Infection was confirmed in all patients by testing sputum and saliva samples. RNA was detected in the stool of 55 (59%) patients and in the serum of 39 (41%) patients. The urine sample from one patient was positive for SARS-CoV-2. The median duration of virus in stool (22 days, interquartile range 17-31 days) was significantly longer than in respiratory (18 days, 13-29 days; P=0.02) and serum samples (16 days, 11-21 days; P<0.001). The median duration of virus in the respiratory samples of patients with severe disease (21 days, 14-30 days) was significantly longer than in patients with mild disease (14 days, 10-21 days; P=0.04). In the mild group, the viral loads peaked in respiratory samples in the second week from disease onset, whereas viral load continued to be high during the third week in the severe group. Virus duration was longer in patients older than 60 years and in male patients.
Conclusion: The duration of SARS-CoV-2 is significantly longer in stool samples than in respiratory and serum samples, highlighting the need to strengthen the management of stool samples in the prevention and control of the epidemic, and the virus persists longer with higher load and peaks later in the respiratory tissue of patients with severe disease.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the China National Mega-Projects for Infectious Diseases and the National Natural Science Foundation of China, for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Figures
Comment in
-
Persistence of viral RNA in stool samples from patients recovering from covid-19.BMJ. 2020 May 6;369:m1724. doi: 10.1136/bmj.m1724. BMJ. 2020. PMID: 32381489 No abstract available.
Similar articles
-
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23. Lancet Infect Dis. 2020. PMID: 32213337 Free PMC article.
-
Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.Influenza Other Respir Viruses. 2020 Sep;14(5):564-574. doi: 10.1111/irv.12758. Epub 2020 May 19. Influenza Other Respir Viruses. 2020. PMID: 32397011 Free PMC article.
-
Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.J Infect Dis. 2020 Aug 17;222(6):910-918. doi: 10.1093/infdis/jiaa388. J Infect Dis. 2020. PMID: 32614392 Free PMC article.
-
Maternal and infant outcomes of full-term pregnancy combined with COVID-2019 in Wuhan, China: retrospective case series.Arch Gynecol Obstet. 2020 Sep;302(3):545-551. doi: 10.1007/s00404-020-05573-8. Epub 2020 Jul 21. Arch Gynecol Obstet. 2020. PMID: 32696241 Free PMC article. Review.
-
[Characteristics of SARS-CoV-2 and potential pharmacological treatment].Postepy Biochem. 2020 May 9;66(2):83-90. doi: 10.18388/pb.2020_321. Postepy Biochem. 2020. PMID: 32700510 Review. Polish.
Cited by
-
Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment.Viruses. 2022 Aug 11;14(8):1757. doi: 10.3390/v14081757. Viruses. 2022. PMID: 36016378 Free PMC article.
-
Risk Factors for Slow Viral Decline in COVID-19 Patients during the 2022 Omicron Wave.Viruses. 2022 Aug 4;14(8):1714. doi: 10.3390/v14081714. Viruses. 2022. PMID: 36016336 Free PMC article.
-
SARS-CoV-2 triggers complement activation through interactions with heparan sulfate.Clin Transl Immunology. 2022 Aug 18;11(8):e1413. doi: 10.1002/cti2.1413. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35999893 Free PMC article.
-
Designing isolation guidelines for COVID-19 patients with rapid antigen tests.Nat Commun. 2022 Aug 20;13(1):4910. doi: 10.1038/s41467-022-32663-9. Nat Commun. 2022. PMID: 35987759 Free PMC article.
-
Comparison of SARS-CoV-2 spike RNA sequences in feces and nasopharynx indicates intestinal replication.Gut Pathog. 2022 Aug 20;14(1):35. doi: 10.1186/s13099-022-00509-w. Gut Pathog. 2022. PMID: 35987708 Free PMC article.
References
-
- World health organization. Coronavirus disease (COVID-19) outbreak situation. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 22 March 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous